Comparison of intraosseous and submucosal dexamethasone injection in mandibular third molar surgery: A split-mouth randomized clinical trial
International Journal of Oral & Maxillofacial Surgery Nov 03, 2019
Kaewkumnert S, Phithaksinsuk K, Changpoo C, et al. - In this randomized, triple-blind, split-mouth clinical trial, researchers compared the impact of intraosseous dexamethasone injection and submucosal dexamethasone injection on postoperative sequelae following mandibular third molar surgery. According to the side (right and left), 54 mandibular third molars (27 patients) were subdivided; intraosseous injection of dexamethasone (4 mg) was randomly assigned to one side and submucosal injection to the other. Findings revealed that there was no significant difference between the two injection techniques in pain or swelling. Nonetheless, on postoperative day 3, there was a significant difference in trismus, with a better result being shown by submucosal injection. All dexamethasone injection methods have been successful in controlling pain and swelling following third-molar mandibular surgery, but the submucosal injection was superior for trismus control.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries